GPD-1116
GPD-1116 is an orally active Phosphodiesterase (PDE) 4 and PDE1 inhibitor. GPD-1116 can reduce smoke-induced apoptosis of lung cells. GPD-1116 is effective in several disease models in animals, including emphysema, acute lung injury, chronic obstructive pulmonary disease (COPD), asthma and pulmonary hypertension[1].
Product Specifications
CAS Number
690690-72-3
UNSPSC
12352005
Target
Apoptosis; Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/gpd-1116.html
Smiles
O=C1C2=C(C3=C(N1C4=CC=CC=C4)N=CC=C3)NN=C2CC5=CC=CC=C5
Molecular Formula
C22H16N4O
Molecular Weight
352.39
References & Citations
[1]Nose T, et, al. Pharmacological Profile of GPD-1116, an Inhibitor of Phosphodiesterase 4. Biol Pharm Bull. 2016;39 (5) :689-98.|[2]Mori H, et, al. Phosphodiesterase 4 inhibitor GPD-1116 markedly attenuates the development of cigarette smoke-induced emphysema in senescence-accelerated mice P1 strain. Am J Physiol Lung Cell Mol Physiol. 2008 Feb;294 (2) :L196-204.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
HA723876 100 µL
Mouse L-Selectin / CD62L Recombinant Rabbit monoclonal Antibody
Sign In for Pricing
View Details 
TRC-D417735-50MG 50 mg
(S)-2,6-Diamino-N-((S)-5-amino-6-oxo-6-(((S)-1-phenylpropan-2-yl)amino)hexyl)hexanamide Trihydrochloride Hydrate
Sign In for Pricing
View Details 
